Viewing Study NCT01305460


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2025-12-27 @ 1:43 PM
Study NCT ID: NCT01305460
Status: COMPLETED
Last Update Posted: 2021-12-28
First Post: 2011-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intensified Azacitidine in High Risk Myelodysplastic Syndrome (MDS)
Sponsor: Groupe Francophone des Myelodysplasies
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module